Silverfin false true 31/12/2025 01/01/2025 31/12/2025 P D Whitehurst 26/01/2010 30 April 2026 no description of principal activity 07137182 2025-12-31 07137182 bus:Director1 2025-12-31 07137182 2024-12-31 07137182 core:ShareCapital 2025-12-31 07137182 core:ShareCapital 2024-12-31 07137182 bus:OrdinaryShareClass1 2025-12-31 07137182 2025-01-01 2025-12-31 07137182 bus:FilletedAccounts 2025-01-01 2025-12-31 07137182 bus:SmallEntities 2025-01-01 2025-12-31 07137182 bus:AuditExempt-NoAccountantsReport 2025-01-01 2025-12-31 07137182 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 07137182 bus:Director1 2025-01-01 2025-12-31 07137182 bus:OrdinaryShareClass1 2025-01-01 2025-12-31 07137182 bus:OrdinaryShareClass1 2024-01-01 2024-12-31 iso4217:GBP xbrli:shares

Company No: 07137182 (England and Wales)

ACTISENSE LIMITED

Unaudited Financial Statements
For the financial year ended 31 December 2025
Pages for filing with the registrar

ACTISENSE LIMITED

Unaudited Financial Statements

For the financial year ended 31 December 2025

Contents

ACTISENSE LIMITED

BALANCE SHEET

As at 31 December 2025
ACTISENSE LIMITED

BALANCE SHEET (continued)

As at 31 December 2025
Note 2025 2024
£ £
Current assets
Cash at bank and in hand 2 100 100
100 100
Net current assets 100 100
Total assets less current liabilities 100 100
Net assets 100 100
Capital and reserves
Called-up share capital 3 100 100
Total shareholder's funds 100 100

Actisense Limited (registered number: 07137182) did not trade during the current financial year and has made neither profit nor loss, nor any other comprehensive income. There have been no movements in shareholders’ funds during the current financial year and therefore no Statement of Changes in Equity has been included. For the financial year ending 31 December 2025 the Company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.

Director's responsibilities:

The financial statements of Actisense Limited (registered number: 07137182) were approved and authorised for issue by the Director on 30 April 2026. They were signed on its behalf by:

P D Whitehurst
Director
ACTISENSE LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 December 2025
ACTISENSE LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 December 2025
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

Actisense Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is 21 Harwell Road, Poole, BH17 0GE, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Ordinary share capital

The ordinary share capital of the Company is presented as equity.

2. Cash and cash equivalents

2025 2024
£ £
Cash at bank and in hand 100 100

3. Called-up share capital

2025 2024
£ £
Allotted, called-up and fully-paid
100 Ordinary shares of £ 1.00 each 100 100